Difficulty: Medium
Average Score: 72%
Practice
Which of the following anxiolytics is preferred in patient with limited hepatic function?
Correct answer
A
Rationale
In the context of pharmacology, especially when considering patients with limited hepatic function, selecting the appropriate medication is crucial to prevent adverse effects and ensure optimal therapeutic outcomes. In this scenario, the correct answer is A) Buspirone.
Buspirone is preferred in patients with limited hepatic function because it is primarily metabolized in the liver via CYP3A4 without active metabolites. This means that it has a lower risk of accumulating in patients with hepatic impairment compared to other anxiolytics that are extensively metabolized in the liver. Additionally, buspirone has a low potential for drug interactions, making it a safer choice in patients with hepatic dysfunction.
Let's analyze why the other options are incorrect:
- B) Quazepam is a benzodiazepine that undergoes hepatic metabolism, which can lead to drug accumulation and increased risk of adverse effects in patients with limited hepatic function.
- C) Diazepam and D) Chlordiazepoxide are both benzodiazepines that are extensively metabolized in the liver, leading to prolonged half-lives and increased risk of toxicity in patients with hepatic impairment.
Educationally, understanding the pharmacokinetics and pharmacodynamics of medications in relation to hepatic function is vital for nursing practice. It ensures safe medication administration and promotes patient-centered care by tailoring drug therapy to individual patient needs. By selecting the appropriate medication based on the patient's hepatic status, nurses can optimize treatment outcomes and minimize potential harm, highlighting the importance of individualized care in pharmacology.
Buspirone is preferred in patients with limited hepatic function because it is primarily metabolized in the liver via CYP3A4 without active metabolites. This means that it has a lower risk of accumulating in patients with hepatic impairment compared to other anxiolytics that are extensively metabolized in the liver. Additionally, buspirone has a low potential for drug interactions, making it a safer choice in patients with hepatic dysfunction.
Let's analyze why the other options are incorrect:
- B) Quazepam is a benzodiazepine that undergoes hepatic metabolism, which can lead to drug accumulation and increased risk of adverse effects in patients with limited hepatic function.
- C) Diazepam and D) Chlordiazepoxide are both benzodiazepines that are extensively metabolized in the liver, leading to prolonged half-lives and increased risk of toxicity in patients with hepatic impairment.
Educationally, understanding the pharmacokinetics and pharmacodynamics of medications in relation to hepatic function is vital for nursing practice. It ensures safe medication administration and promotes patient-centered care by tailoring drug therapy to individual patient needs. By selecting the appropriate medication based on the patient's hepatic status, nurses can optimize treatment outcomes and minimize potential harm, highlighting the importance of individualized care in pharmacology.